Research Article

Sarcopenic Obesity and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation?

Table 4

Coefficients predicting cognitive functioning for subjects aged 70+.

Model 1 Model 2 Model 3

Sarcopenic obese −7.08 (1.28)*** −5.66 (1.28)*** −7.19 (1.28)***
Solely sarcopenic −4.19 (0.82)*** −4.39 (0.82)*** −4.20 (0.82)***
Solely obese −1.43 (0.68)* 0.51 (0.73) −1.63 (0.69)*
Black−14.33 (1.19)***−14.23 (1.18)***−14.40 (1.19)***
Hispanic−9.19 (1.01)***−9.56 (1.01)***−9.33 (1.01)***
Other−7.35 (2.03)***−7.40 (2.01)***−7.47 (2.03)***
Age (75–79)−3.10 (0.59)***−2.91 (0.59)***−3.04 (0.59)***
Age (80–84)−8.42 (0.68)***−8.07 (0.67)***−8.35 (0.68)***
Age (85+)−12.02 (0.91)***−12.49 (0.91)***−12.03 (0.91)***
Education2.25 (0.08)***2.21 (0.08)***2.24 (0.08)***
Female3.68 (0.75)***3.04 (0.75)***3.80 (0.75)***
Height−0.11 (0.04)**−0.13 (0.04)**−0.10 (0.04)*
History of CVD−2.63 (0.61)***−2.42 (0.61)***−2.64 (0.61)***
Low physical activity−3.11 (0.57)***−2.83 (0.56)***−3.14 (0.57)***
Hypoalbuminemia−4.12 (1.44)**−4.35 (1.43)**−4.70 (1.45)**
Hyperhomocysteinemia−0.11 (0.89)−0.27 (0.89)−0.26 (0.90)
IRHOMA−3.02 (0.45)***
CRP0.47 (0.24)
squared.387.3970.388

      .